Galmed Pharmaceuticals Ltd expected to post a loss of 83 cents a share - Earnings Preview

Eocene

22/08/2025 21:03

Galmed Pharmaceuticals Ltd GLMD.OQ GLMD.O is expected to  report resultson August 26 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Galmed Pharmaceuticals Ltd is for a loss of 83 cents per share.

The one available analyst rating on the shares is "hold".

The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated August 22 at 20:03 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)